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 The binding modes of TETD and BSA/
HSA have been established.
 The binding sites on BSA/HSA by
TETD were discussed.
 MCR-ALS was applied to interpret the
interaction between TETD and BSA/
HSA.
 Investigating the structural changes
of proteins.
 Further information was extracted by
chemometrics methods.g r a p h i c a l a b s t r a c t
The interactions of tetrandrine (TETD) with two serum albumins (BSA and HSA) have been investigated
using multispectroscopic and chemometrics methods at different temperatures under imitated physio-
logical conditions. These spectra data measured were further analyzed by multivariate curve resolu-
tion-alternating least squares (MCR-ALS) and the concentration proﬁles for three species (BSA/HSA,
TETD and TETD-BSA/HSA) existed in the interaction procedure.a r t i c l e i n f o
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The binding interactions of tetrandrine (TETD) with bovine serum albumin (BSA) and human serum
albumin (HSA) have been investigated by spectroscopic methods. These experimental data were further
analyzed using multivariate curve resolution-alternating least squares (MCR-ALS) method, and the
concentration proﬁles and pure spectra for three species (BSA/HSA, TETD and TETD-BSA/HSA) existed
in the interaction procedure, as well as, the apparent equilibrium constants Kapp were evaluated. The
binding sites number n and the binding constants K were obtained at various temperatures. The binding
distance between TETD and BSA/HSA was 1.455/1.451 nm. The site markers competitive experiments
indicated that TETD primarily bound to the tryptophan residue of BSA/HSA within site I. The thermody-
namic parameters (DG, DH and DS) calculated on the basis of different temperatures revealed that the
binding of TETD-BSA was mainly depended on the hydrophobic interaction strongly and electrostatic
interaction, and yet the binding of TETD-HSA was strongly relied on the hydrophobic interaction. The
results of synchronous ﬂuorescence, 3D ﬂuorescence and FT-IR spectra show that the conformation of
proteins has altered in the presence of TETD. In addition, the effect of some common ions on the binding
constants between TETD and proteins were also discussed.
2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.
Scheme 1. Chemical structure of TETD.
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Tetrandrine (TETD, a bis-benzylisoquinoline alkaloid, Scheme 1),
an extract from the root of Hang-Fang-Chi (Stephania tetrandra S.
Moore), has been reported to have many pharmacological effects
including immunosuppressive, non-selective Ca2+ channel Block-
ing, anti-proliferative, anti-oxidant, anti-ﬁbrotic and anti-tumor
(such as, breast cancer, lung cancer, neuroblastoma, Burkitt’s lym-
phoma, hepatocellular carcinoma, colon cancer, nasopharyngeal
carcinoma, glioma and leukemia) activity [1–5]. For several dec-
ades, TETD has been used in China to treat patients with arthritis,
arrhythmia, hypertension, inﬂammation, and silicosis [2]. More-
over, TETD exhibits synergistic effects with chemotherapeutics in
restricting tumor cell proliferation [6], but the molecular mecha-
nisms underlying its anti-tumor efﬁcacy remain poorly under-
stood. Later, Cheng et al. [7] investigated the mechanisms by
utilizing two-dimensional gel electrophoresis (2DE), and their
studies suggested that TETD could inhibit HepG2 cells proliferation
and might exert its effect on liver cancer at least partially through
regulating these proteins’ expression directly or indirectly. How-
ever, further study of these proteins will be helpful to further elu-
cidate anti-tumor mechanism of TETD and identify new targets of
drugs for chemotherapy. In addition, TETD can reduce portal ve-
nous pressure, prevent diabetes, ameliorate the reperfusion injury
in porcine intestinal transplantation, inhibit calcium channels, li-
pid peroxidation and proliferation of vascular smooth muscle cells
[8]. Gong et al. [9] reported that TETDmight alleviate the fulminant
hepatic failure (FHF) induced by LPS/D-GalN and reduce TNF-a
production through inhibiting NF-jB activation. Recently studies
[10,11] have demonstrated that TETD may provide a therapeutic
approach for AD (Alzheimer’s disease), and inhibit HSFs (hypertro-
phic scar ﬁbroblasts) at least partially through induction of Smad7
and decrement of Smad2 resulting in inhibition of TGF-b1 (trans-
forming growth factor b1) transcription and its intracellular signal-
ing. In 2007, Wang et al. [12] reported that the binding of effective
component (such as, TETD) of Chinese herbs with HSA were inves-
tigated by spectroscopic methods. Latterly, they [13] studied the
interaction between TETD and BSA by ﬂuorescence spectroscopy.
But, identifying binding sites between TETD and BSA/HSA, further
exploring the structural change of BSA/HSA (such as, FTIR, 3D ﬂuo-
rescence spectra methods) and investigating the inﬂuences of com-
mon ions on the interaction of proteins with TETD need still be
discussed. However, in order to understand detailedly its pharma-
cological importance, the interactions of proteins with TETD have
been investigated thoroughly because the binding phenomena
can not only provide some useful information for understanding
pharmacological actions, bio-information, bio-distribution, etc.,
but also illustrate its binding mechanism at a molecular level
and design its analogues with effective pharmacological properties.
Serum albumins (SAs) are the most abundant protein in plasma,
and participate in the binding and transportation of various li-
gands, such as fatty acids, hormones and drugs [14]. So, serum
albumin is often employed as a model for studying the interaction
of drug with protein in vitro. Many drugs and other bioactive smallmolecules bind reversibly to albumin and other serum compo-
nents, which then function as carriers. Among albumins, bovine
serum albumin (BSA) and human serum albumin (HSA) have been
widely used as models in evaluating the interactions between li-
gands and proteins owing to their similar folding and well-known
primary structure [15].
In recent years, some research groups [16–26] have reported
the interactions of different drugs with proteins by different tech-
niques, such as, spectroscopic (FTIR, CD, ﬂuorescence, synchro-
nous ﬂuorescence, UV–vis absorption and 3D ﬂuorescence
spectra), HPLC, electrochemistry, capillary electrophoresis, density
functional theory (DFT) calculations, molecular docking, NMR
spectroscopy, isothermal titration calorimetry (ITC), scanning
electron microscope (SEM) and transmission electron microscopy
(TEM) analyses. However, in the multicomponent reaction sys-
tems reported above, if researchers are hoping to estimate simul-
taneously, the amounts of the small molecule, the biopolymer
and their complex product, the analytical tasks should become
quite difﬁcult and challenging by the common methods of data
interpretation. Therefore, in order to solve the difﬁcult questions,
chemometrics methods such as multivariate curve resolution-
alternating least squares (MCR-ALS) method [27] are applied.
Up to now, a few research groups [28–32] reported the interac-
tions between various small molecules (such as drugs) and bio-
polymer (such as, polynucleotide, BSA and DNA) by
ﬂuorescence, UV–vis spectra, electrochemistry and other methods
with the aid of MCR-ALS method. Moreover, in these binding
reaction systems, further information can be obtained, for exam-
ple, the formation of the complex, the concentration proﬁles and
pure spectra for each species.
In the present work, the interaction between TETD and BSA/HSA
has been investigated in vitro using ﬂuorescence, UV–vis and FTIR
spectra techniques under physiological conditions. The association
constants, the thermodynamic parameters, the number of binding
sites, the binding forces and the energy transfer distance of TETD-
BSA/HSA complexes were estimated. At the same time, the effect of
TETD on the microenvironment and conformation of proteins was
also discussed. Moreover, the MCR-ALS method was applied to re-
solve the two-way UV–vis and ﬂuorescence spectra data so that it
can help us to understand further the complex kinetic processes
and extract the equilibrium proﬁles of the reacting species. In addi-
tion, the binding mechanism of TETD with BSA/HSA was explored.
We believe that these studies will be useful to design and synthesis
of TETD derivatives with high activity and their pharmaceutical
research.Experimental
Materials
Bovine serum albumin (BSA, FractionV, 98% purity, Mr = 68000)
purchased from Roche Company, and human serum albumin (HSA,
96% purity, Mr = 66000) purchased from Sigma–Aldrich, were used
without further puriﬁcation. They were both dissolved in the Tris–
HCl buffer solution (pH 7.4) to form a solution of 2.0  104 -
mol L1 and then stored in the dark at 4 C. Tetrandrine (TETD,
98% purity) was obtained from Shanghai Source Leaf Biological
Technology Co., Ltd. (Shanghai, China). The stock solution of TETD
was prepared by dissolving the crystals into 10% acetone with the
ﬁnal concentration of 6.0  104 mol L1. Other materials were of
analytical reagent grade and also used without further puriﬁcation.
Doubly distilled water was used throughout the experiment. Sam-
ple masses were accurately weighed on an electronic analytical
balance ESJ200-4 (Shenyang Longteng Electronic Co., Ltd., China)
with a resolution of 0.1 mg.
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All ﬂuorescence measurements were carried out on a Cary
Eclipse ﬂuorescence spectroﬂuorometer (Varian, USA) equipped
with a xenon lamp source and 1.0 cm quartz cell and a thermostat
bath. UV–vis absorption spectra were collected on a UV-3600 spec-
trophotometer (Shimadzu, Japan) in 1.0 cm quartz cells at room
temperature. FTIR spectra were performed on a Nicolet-6700 FTIR
spectrometer (Nicolet, USA) equipped with the attenuated total
reﬂection (ATR) accessory. The MCR-ALS programs [33] were used
to process the collected spectra data, if necessary.
Experimental procedure
Fluorescence quenching measurements
Fluorometric titration experiments: 3.0 mL of BSA/HSA solution
(5.0  106 mol L1) was added accurately to the quartz cell and
then titrated by successive additions of TETD solution with the
concentration of 6.0  104 mol L1 using a 50 lL microsyringe to
attain a series of ﬁnal concentrations (0–16.0  106 mol L1 with
an interval of 2.0  106 mol L1). Titrations were operated manu-
ally and mixed moderately. Fluorescence emission spectra were
measured at 293, 298, 304 and 310 K with the width of the excita-
tion and emission slits both adjusted at 5 nm. The excitation wave-
length was 280 nm, and ﬂuorescence emission spectra were
recorded in the range of 300–500 nm. Synchronous ﬂuorescence
spectra were recorded from 240 to 320 nm at Dk = 15 and 60 nm,
respectively. Also appropriate blanks corresponding to the buffer
were subtracted to correct the ﬂuorescence background.
Three-dimensional ﬂuorescence spectra of free BSA/HSA and
TETD-BSA/HSA complex were recorded under the following condi-
tions: the initial excitation wavelength was set at 200 nm with
increment of 2 nm, and the emission wavelength was recorded be-
tween 200 and 450 nm at a scanning rate of 24000 nm/min, and
other scanning parameters were the same as those of ﬂuorescence
quenching spectra.
Site marker competitive experiments
The binding studies between TETD and BSA/HSA were per-
formed using the ﬂuorescence titration method in the presence
of three site markers (ibuprofen, phenylbutazone and digitoxin).
The concentrations of BSA/HSA and site markers were all stabilized
at 5.0  106 mol L1(pH 7.4). The solution of TETD was gradually
added to the BSA-ibuprofen, BSA-phenylbutazone, BSA-digitoxin,
HSA-ibuprofen, HSA-phenylbutazone, or HSA-digitoxin mixtures.
The ﬂuorescence quenching data for six systems were recorded
in the range of 300–500 nm using an excitation wavelength of
280 nm.
FTIR spectra experiments
FTIR spectra of free BSA/HSA and TETD-BSA/HSA complex were
performed on a Nicolet-6700 FTIR spectrometer equipped with the
attenuated total reﬂection (ATR) accessory, a DTGS KBr detector
and a KBr beam splitter. FTIR spectra were taken via the ATR meth-
od at a resolution of 4 cm1 and 64 scans. Their FTIR spectra were
recorded in the range of 400–4000 cm1 at 298 K. The correspond-
ing absorbance contributions of buffer and free TETD solutionsTable 1
The experiments to build up the extension matrixes.
Experiment cBSA/HSA (lM) cTETD (lM)
1 5.0 0–16.0
2 0–7.57 9.84
For each experiment, UV–vis (220–320 nm, NUV = 101 wavelength points), and ﬂuorescewere recorded and digitally subtracted with the same instrumental
parameters.
Mole-ratio methods with ﬂuorescence and UV–vis detection
Fluorescence and UV–vis spectroscopic titrations were carried
out at 298 K in the Tris–HCl buffer of pH 7.4. Two separate exper-
iments (Table 1) were performed by the mole-ratio method. Exper-
iment 1: the concentration of BSA/HSA was kept constant
(5.0  106 mol L1), and different amounts of TETD (range: 0–
16.0  106 mol L1 with an interval of 8.0  107 mol L1) were
added to the solution; Experiment 2: the concentration of TETD
was kept constant (9.84  106 mol L1) and different amounts of
BSA/HSA were added to the solution with a range of 0–
7.57  106 mol L1. Each solution was allowed to keep 10 min,
and then their UV–vis (220–320 nm) and ﬂuorescence (300–
450 nm) spectra (the scanning parameters were the same as those
of ﬂuorescence quenching spectra) were collected at every 1 and
2 nm, respectively. Thus, four data matrices DBSA=HSAF ;D
BSA=HSA
UV ,
DTETDBSA=HSAF and D
TETDBSA=HSA
UV were obtained from these measure-
ments; these column- and row-wise expanded data matrix with
two different measuring approaches for the two types of experi-
ments was constructed.
Chemometrics methods
Multivariate curve resolution-alternating least squares (MCR-
ALS) is a commonly used technique and it can resolve the multi-
component mixtures into a simple model consisting of a composi-
tion-weighted sum of the signals of the pure compounds [30]. UV–
vis and ﬂuorescence data were analyzed by MCR-ALS method in or-
der to evaluate concentration proﬁles and pure spectra of chemical
components simultaneously from decomposition of a multivariate
multicomponent experimental data matrix D (MR MC) based on
the Beer’s law:
D ¼ CST þ E ð1Þ
where the columns in the C (MR MF) and the rows in the ST (MF -
MC) are data matrices containing concentration proﬁles and pure
component spectra presented in the experiment, respectively; the
superscript ‘‘T’’ means the transpose of matrix S; E (MR MC) is
the matrix of residuals not explained by the model and ideally
should be close to the experimental error. MR and MC are the num-
ber of spectra recorded throughout the process and the instrumen-
tal responses measured at each wavelength, respectively. MF is the
number of main components in data matrix D, which can be esti-
mated by different methods (such as, singular value decomposition
(SVD), evolving factor analysis (EFA) or SIMPLISMA) [30]. Once MF
has been determined, an initial estimate of their concentration pro-
ﬁles can be obtained from EFA plots, it becomes easier to obtain im-
proved estimates of either the concentration values or pure
measured proﬁles. In order to facilitate the ﬁnding of pure or most
representative contributions to the data matrix using real variables,
the constraints of ALS optimization (such as, non-negative and uni-
modal solutions) should be implemented. During the optimization,
the above constraints are applied to ensure that the ﬁnal solution is
chemically meaningful [31]. However, the solutions to Eq. (1) ob-
tained by MCR-ALS are not unique because of rotational ambiguitiesNumber of spectra Data matrix
21 DBSA=HSAF D
BSA=HSA
UV
25 DTETDBSA=HSAF D
TETDBSA=HSA
UV
nce (300–450 nm, NF = 76 wavelength points) spectra were recorded.
Z. Cheng et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 115 (2013) 92–105 95and rank-deﬁciency problems. In order to solve the limitation, a
powerful extension of MCR-ALS is developed to deal with multiple
data matrices simultaneously [34]. In the paper, four data matrices
were obtained by two types of experiment and two different mea-
suring approaches. The data arrangement evaluated by the ex-
tended MCR-ALS analysis is shown below:
DBSA=HSAF D
BSA=HSA
UV
DTETDBSA=HSAF D
TETDBSA=HSA
UV
" #
¼ C
BSA=HSA
CTETD
" #
 STFSTUV
h i
þ E
BSA=HSA
F E
BSA=HSA
UV
ETETDBSA=HSAF E
TETDBSA=HSA
UV
" #
ð2Þ
where the superscripts BSA/HSA and TETD-BSA/HSA denote exper-
iments 1 and 2 in Section Mole-ratio methods with ﬂuorescence
and UV–vis detection, respectively. The ﬁrst term is the augmented
experimental data matrix containing ﬂuorescence and UV–vis spec-
tra data from the two experiments; [CBSA/HSA and CTETD] is the data
matrix, which contains the recovered MCR-ALS concentration pro-
ﬁles for the two experiments; ½STFSTUV is the data matrix of the sim-
ulated pure spectra for each species; the last term is the residual
variance. A number of four individual data matrices are simulta-
neously analyzed using Eq. (2).Results and discussion
Analysis of ﬂuorescence and UV–vis spectra by MCR-ALS method
The interactions between TETD and BSA/HSA have been investi-
gated by ﬂuorescence and UV–vis spectra. Fig. 1 shows the spectro-
scopic data obtained from the experiments 1 and 2 in Table 1.
Fluorescence of BSA/HSA originates from tryptophan, tyrosine and
phenylalanine residues, where the intrinsic ﬂuorescence of BSA/HSA
mainly contributesby the tryptophan residuealone. Fig. 1A–Ddisplays
the ﬂuorescence spectra obtained from the above two different titra-
tions (see Section Mole-ratio methods with ﬂuorescence and UV–vis
detection). Fig. 1E–H corresponds to their UV–vis spectra. With
increasing the concentrations of TETD, the ﬂuorescence intensities of
serum albumins decreased. It could be seen from Fig. 1A and B that
the ﬂuorescence intensities of tryptophan residues (k = 338 nm for
HSA/BSA) were speciﬁcally quenched. Fluorescence spectra of TETD
in the presence of various concentrations of BSA/HSA (Fig. 1C and D)
showed that TETDﬂuorescence intensity increased slightly, and simul-
taneously, a new BSA/HSA ﬂuorescence peak appeared at 338 nm.
Moreover, the shapeandpositionof fourdifferent typesofﬂuorescence
peaks did not change. UV–vis spectra of BSA/HSA (Fig. 1E and F)
showed peaks at 278 nm whose intensities increased with increasing
the concentrations of TETD and blue shifts in their maximum absorp-
tion wavelength could be also observed. A similar situation was ob-
served for TETD in the presence of BSA/HSA (Fig. 1G and H). The
results indicated that the microenvironment of tryptophan residues
on BSA/HSA altered, the peptides strand less extended, and the hydro-
phobicity increased with the addition of TETD [35].
However, it is difﬁcult to deduce the formation of a complex in the
binding reaction systems based on ﬂuorescence and UV–vis spectra
alone (Fig. 1A–H), because the high spectral overlap is observed for
each species. Therefore, the MCR-ALS method has been applied to ob-
tain further informations, which include ascertaining the formation of
TETD-BSA/HSAcomplex, obtaining the concentrationproﬁles andpure
spectra for eachspecies, calculating theapparentequilibriumconstant,
and exploring the essence of the drug’s affection on BSA/HSA.
In order to apply MCR-ALS, the following steps were imple-
mented as follows:
(1) The expanded data matrix was established by Eq. (2); (2) the
number of factors which could be related to chemical species, was
evaluated by EFA method and the initial concentrations of the spe-
cies existed in the binding procedure were estimated; (3) MCR-ALS
constrained optimization was applied with an initial estimate of
the concentration proﬁles obtained from EFA for the three speciespostulated (i.e., the calculated concentrations were constrained to
be non-negative and to give unimodal proﬁles; a closure constraint
for the concentration proﬁles was also constrained to based on the
total concentration of TETD and BSA/HSA) and (4) running the
MCR-ALS program.
Fig. 2A–D displays the pure ﬂuorescence and UV–vis spectra
simulated for different species, which correspond to STF and S
T
UV,
respectively. These ﬂuorescence and UV–vis spectra simulated
(dashed line) compared with the spectra measured (solid line),
and agreed well with them. Moreover, the ﬂuorescence and UV–
vis spectra of TETD-BSA/HSA complex were also obtained (see
dashed line of TETD-BSA/HSA in Fig. 2A–D. Furthermore, the con-
centration proﬁles of free BSA or HSA, free TETD and TETD-BSA/
HSA complex in the binding procedure (see their ﬁtted curves in
Fig. 2E–H), were obtained by MCR-ALS method, which otherwise,
were difﬁcult to obtain by conventional methods. As shown in
Fig. 2B, a slightly blue shift in the maximum emission wavelength
could be observed from free HSA to TETD-HSA complex and a
slightly red shift could also be seen in the absorbance spectra
(Fig. 2C and D) of free BSA/HSA when TETD was added, suggesting
that the conformation and/or microenvironment of BSA/HSA al-
tered in the presence of TETD.
The concentration proﬁles simulated by MCR-ALS method are
shown in Fig. 2E–H. The two plots correspond to data matrices CBSA/
HSA and CTETD, respectively. The recovered concentration proﬁles dis-
played the expected trends of the different type of experiments. For
experiments 1 (Fig. 2E and F), the concentration of TETD-BSA/HSA
complex increased sharply and approached to the equilibriumwhen
CTETD/CBSA/HSAwas2.40,while for experiments 2 (Fig. 2GandH),when
the ratio of CBSA/HSA:CTETD was greater than 0.42, the concentration of
the complex increased slowly with increasing the concentration of
BSA/HSA, indicating that the binding reaction reached to the equilib-
rium. Furthermore, the apparent equilibrium constant (Kapp(TETD-
BSA/HSA)) [28] of TETD-BSA/HSA complex can be calculated from
the estimated concentration proﬁles:
KappðTETD BSA=HSAÞ ¼ ½TETD BSA=HSA½TETD½BSA=HSA ð3Þ
where [TETD], [BSA/HSA] and [TETD-BSA/HSA] are the estimated
concentrations of free TETD, free BSA/HSA and corresponding com-
plexes, respectively. The CTETD/CBSA/HSA for the complex was 2.40
(Fig. 2E and F), and the Kapp(TETD-BSA/HSA) value was obtained
as 5.16  106/2.05  106 L mol1 according to Eq. (3). The CBSA/HSA/
CTETD for the complex was 0.42 in Fig. 2G and H), and the value of
Kapp(TETD-BSA/HSA) was calculated as 7.46  106/4.81  106 -
L mol1. Therefore, the values of Kapp(TETD-BSA) and Kapp(TETD-
HSA) obtained from the two different cases were similar, which
suggested that there was a strong interaction force between TETD
and BSA/HSA, and the drug may stay in the blood plasma for a long
time and play a profound poisonous effect [28]. Moreover, it could
be seen from Fig. 2E and F that the molar concentration ratios
(CTETD/CBSA and CTETD/CHSA) in the two complexes were close to 2,
indicating that there was one binding site per two base pairs at dif-
ferent experimental conditions [36]. As described above, the values
of Kapp(TETD-BSA/HSA) were in good agreement with the one calcu-
lated by conventional method (see Section Binding constant and
binding sites of BSA/HSA with TETD and Table 2) because of them
being of the same order of magnitude, i.e. 106.Fluorescence quenching and FTIR spectra study
Binding constant and binding sites of BSA/HSA with TETD
According to the results discussed in Section Analysis of ﬂuores-
cence and UV–vis spectra by MCR-ALS method, the TETD-BSA and
TETD-HSA complexes could be formed. In order to obtain the
Fig. 1. Spectra obtained from different experiments. Experiment 1: (A and B) f1uorescence ðDBSAF and DHSAF Þ and (E and F) UV–vis ðDBSAUV and DHSAUV Þ, cBSA = cHSA = 5.0 lM, cTETD
(lM) 1–21:0, 0.8, 1.6, . . ., 16.0, respectively. Experiment 2: (C and D) f1uorescence ðDTETDBSAF and DTETDHSAF Þ and (G and H) UV–vis ðDTETDBSAUV and DTETDHSAUV Þ, cTETD = 9.84 lM,
cBSA/HSA = 0, 0.33, 0.65, 0.98, 1.30, 1.63, 1.95, 2.27, 2.59, 2.91, 3.23, 3.54, 3.86, 4.17, 4.49, 4.80, 5.11, 5.42, 5.73, 6.04, 6.35, 6.66, 6.96, 7.27, 7.57 lM for curves 1–25, respectively.
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Fig. 2. The simultaneous analysis results of UV–vis and ﬂuorescence data of the two experiments by MCR-ALS method. Recovered ﬂuorescence (A and B) and UV–vis (C and D)
spectra (solid and dashed line denote experimental and simulative values, respectively); recovered concentration proﬁles for Experiment 1 (E and F) and Experiment 2 (G and
H), respectively.
Z. Cheng et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 115 (2013) 92–105 97
Table 2
The binding constants K, the number of binding sites n, and the thermodynamic parameters of BSA-TETD and HSA-TETD systems at different temperatures.
System T (K) K  106 (L mol1) n Ra DG (kJ mol1) DH (kJ mol1) DS (J mol1 K1) Rb
BSA-TETD 293 1.31 1.20 0.9978 34.28 27.61 22.77 0.9982
298 1.06 1.17 0.9958 34.39
304 0.84 1.15 0.9982 34.53
310 0.70 1.13 0.9958 34.67
HSA-TETD 293 1.17 1.19 0.9978 33.90 59.15 317.58 0.9922
298 1.59 1.21 0.9983 35.49
304 2.47 1.24 0.9992 37.40
310 4.47 1.28 0.9975 39.30
a R is the correlation coefﬁcient for K values.
b R is the correlation coefﬁcient for the van’t Hoff plot.
Fig. 3. Stern–Volmer plots for BSA (A) and HSA (B) with TETD at (j) 293 K, (h)
298 K, (N) 304 K and (O) 310 K.
98 Z. Cheng et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 115 (2013) 92–105binding constant of the two complexes, the binding reactions were
carried out at four different temperatures (Section Fluorescence
quenching measurements), and these ﬂuorescence spectra data
were analyzed by the Stern–Volmer equation [37]:Table 3
The parameters of Stern–Volmer plots for the quenching of BSA and HSA by TETD at four
T (K) BSA-TETD
Ksv (105 M1) Kq (1013 M1 s1) Ra SD
293 1.58 1.58 0.9936 0.0945
298 1.74 1.74 0.9921 0.1167
304 1.81 1.81 0.9950 0.0960
310 1.84 1.84 0.9919 0.1247
a R is the correlation coefﬁcient for the Stern–Volmer plot.F0
F
¼ 1þ Ksv½Q  ¼ 1þ Kqs0½Q  ð4Þ
where F0 and F denote steady-state ﬂuorescence intensities in the
absence and presence of quencher, respectively; Ksv, Kq, and [Q] rep-
resent the Stern–Volmer quenching constant, the quenching rate
constant of biomolecule, and the concentration of quencher, respec-
tively; s0 is the average lifetime of protein without the quencher,
and the ﬂuorescence lifetime of biopolymer is taken as 108 s
[38]. The plots of F0/F versus [Q] were shown in Fig. 3. Moreover,
the plots exhibited fairly good linear relationships (R > 0.9918), sug-
gesting that a single type of quenching phenomenon, either static or
dynamic quenching occurred in the formation of TETD-BSA/HSA
complexes. The values of Ksv, Kq, R and SD are listed in Table 3. As
shown in Table 3, the values of Ksv increased with increasing the
temperature, indicating that the predominant quenching mecha-
nism was the dynamic quenching.
However, the static quenching effect of the complex formation
could not be completely precluded in the present study. Firstly, the
analysis of ﬂuorescence and UV–vis spectra data by MCR-ALS
above has conﬁrmed the formation of TETD-BSA and TETD-HSA
complexes. Secondly, the maximum scatter collision quenching
constant of various quenchers with the biopolymers is 2  1010 -
L mol1 s1 [39] while those of BSA/HSA quenching procedure ini-
tiated by TETD (Table 3) are far greater than this value. Therefore,
the ﬂuorescence quenching mechanism of BSA/HSA by TETD is a
combination of the static and dynamic quenching. However, for
the static quenching interaction, if it is assumed that there are sim-
ilar and independent binding sites in the bio-molecule, the binding
constant (K) and the number of binding sites (n) could be deter-
mined according to the following equation [40]:
log½ðF0  FÞ=F ¼ logK þ n log½Q  ð5Þ
where F0, F, and [Q] are the same as in Eq. (4), K is the binding con-
stant of TETD with BSA/HSA and n is the number of binding sites per
albumin molecule, which can be determined by the slope and inter-
cept of double logarithm regression curve of log [(F0–F)/F] versus
log [Q] based on Eq. (5) (Fig. 4). Table 2 shows the values of K and
n at different temperatures analyzed in this way for BSA/HSA. As
could be seen in Table 2, the calculated binding constants fordifferent temperatures.
HSA-TETD
Ksv (105 M1) Kq (1013 M1 s1) Ra SD
1.60 1.60 0.9948 0.0865
1.75 1.75 0.9973 0.0994
1.83 1.83 0.9944 0.1030
2.04 2.04 0.9985 0.0596
Fig. 4. Plots of log [(F0–F)/F] vs. log [Q] for the BSA-TETD (A) and HSA-TETD (B)
systems at four different temperatures, cBSA = cHSA = 5.0 lM; pH = 7.4.
Fig. 5. Linear ﬁtting plots of log [(F0–F)/F] vs. log [Q] for the BSA-TETD (A) and HSA-
TETD (B) systems in the absence and presence of the site markers (T = 298 K,
pH = 7.4).
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to other weak protein–ligand complexes with binding constants
range from 103 to 105 M1 [20,41–43]. The value of n is helpful to
knowing the number of binding sites and locating the binding site
in BSA and HSA for drugs. The n values of TETD-BSA and TETD-
HSA complexes are approximately equal to 1, indicating that there
is one binding site in both BSA and HSA for TETD during their inter-
actions, which was consistent with the result by Wang et al. re-
ported [12,13]. Hence, TETD most likely bound to the hydrophobic
pocket located in subdomain IIA of proteins; that is to say, Trp-
212 /Trp-214 residues on BSA/HSA are near or within the binding
site [44]. Whereas, larger number of bound lipid (n) was reported
for HSA with Chol (n = 1.22), DDAB (n = 1.82), DOTAP (n = 1.56),
and DOPE (n = 1.76) [45]. The strong binding force and one afﬁnity
binding site were identical with the extraction information from the
MCR-ALS method, which was of particular signiﬁcance to pave the
way for better understanding the interaction between TETD and
BSA/HSA.
Because the data discussed in the sections above could not
identify the precise binding site, the site competitive replacement
experiments were conducted at 298 K by drugs speciﬁcally binding
to a known site or region on proteins (BSA and HSA). Proteins are
made up of three homologous a-helix domains (I-III), and each do-
main contains two subdomains (A and B). The binding sites of pro-
teins for endogenous and exogenous ligands may be in these
domains, and the principal regions of binding sites on proteins
are located in the hydrophobic cavities in subdomains IIA or IIIA.
Many ligands could bind speciﬁcally to serum albumins, such as,
phenylbutazone and warfarin for site I, ibuprofen and ﬂufenamic
acid for site II, and digitoxin for site III [46]. In order to ascertainthe binding site on HSA/BSA by TETD, the displacement experi-
ments were performed using site probes (for example, phenylbuta-
zone (PB), ibuprofen (IB) and digitoxin (DIG)). The solution of TETD
was gradually titrated to the system of protein with the site marker
while the concentration of protein to the site marker was kept at
1:1. Then, their ﬂuorescence intensities were recorded in the range
of 300–500 nm, and their ﬂuorescence quenching data were ana-
lyzed by Eq. (5) (Fig. 5). In order to compare the effects of PB, IB
and DIG on the binding of TETD to BSA/HSA, the binding constant
and other parameters were calculated and listed in Table 4. Obvi-
ously, the binding constants of TETD-BSA/HSA with PB were
66.04%/28.30% of that without PB, while the binding constants of
TETD-BSA/HSA with and without IB or DIG had only a small differ-
ence. These revealed that the competition between TETD and PB, IB
or DIG was really in existence, and TETD mainly competed with PB
in subdomain IIA (site I). This indicates that TETD mainly binds to
BSA/HSA in site I. The binding sites of TETD to proteins were the
same as N0-(2,4-dimethoxybenzylidene)-2-hydroxybenzohydraz-
ide (DBH) to BSA [17].
Thermodynamic parameters and binding forces
Generally, small molecules are bound to biological macromole-
cules by a combination of forces which include hydrogen bond, van
der-waals force, electrostatic force, and hydrophobic interaction
force [47]. The signs and magnitudes of thermodynamic parame-
ters (such as, enthalpy change (DH) and entropy change (DS))
can account for main forces involved in the binding process. For
this reason, thermodynamic parameters dependent binding con-
stants are studied and they are calculated by the van’t Hoff
equation:
Table 4
Effects of the site probe on the quenching constants between TETD and BSA/HSA.
Blank With IB With PB With DIG
K (106 M1) R K (106 M1) R K (106 M1) R K (106 M1) R
BSA-TETD 1.06 0.9958 1.42 0.9974 0.70 0.9957 1.00 0.9986
HSA-TETD 1.59 0.9983 2.40 0.9972 0.45 0.9976 0.71 0.9989
Fig. 6. The spectral overlap of UV–vis absorption spectrum of TETD and ﬂuores-
cence emission spectra of BSA and HSA; (a) the ﬂuorescence emission spectrum of
BSA; (b) the UV–vis absorption spectrum of TETD and (c) the ﬂuorescence emission
spectrum of HSA. c(BSA) = c(HSA) = 5.0 lM, c(TETD) = 10.0 lM, T = 298 K.
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where K is binding constant at temperature T and R is gas constant.
The binding studies were carried out at four different temperatures
(293, 298, 304 and 310 K). Moreover, at these temperatures, pro-
teins (BSA and HSA) don’t undergo any structural degradation.
Assuming that there is no signiﬁcant change of the DH values in
the temperature range, the free energy change (DG) can be calcu-
lated from Eq. (7).
DG ¼ DH  TDS ¼ RT lnK ð7Þ
The values of DH, DS and DG are summarized in Table 2. As shown
in Table 2, the negative values of DG (from 39.30 to
33.90 kJ mol1) suggested that the two binding processes were
spontaneous. The DH and DS values for the binding interaction be-
tween TETD and BSA were found to be 27.61 kJ mol1 and
22.77 J mol1 K1, which indicated that the formation of TETD-
BSA complex was an exothermic reaction accompanied by a posi-
tive DS value. From the point of view of water structure, a positive
DS value was frequently taken as a typical evidence for the hydro-
phobic interactions. Whereas, the positive DS and negative DH val-
ues suggested that there was speciﬁc electrostatic interactions
between ionic species in an aqueous solution. But, the negative
DH value (27.61 kJ mol1) observed in the present work couldn’t
mainly attribute to electrostatic interactions since DH was very
small, almost zero for this binding interaction [48]. Obviously, it
was not possible to account for the thermodynamic parameters
based on a single intermolecular force model. In the present case
of TETD-BSA complex, the binding reaction should be the hydropho-
bic interactions strongly, but the electrostatic interactions could
also not be excluded as stated above. Meanwhile, it was found that
the major contribution toDG arose fromDH rather than fromDS, so
the binding process was enthalpy driven, and the increase of entro-
py might be based on the destruction of the iceberg structure in-
duced by the hydrophobic interactions. And yet, the positive
enthalpy (DH = 59.15 kJ mol1) and entropy (DS = 317.58 J mol1 -
K1) values for the interaction of TETD with HSA were typical of
those associated with the hydrophobic interactions [48], which
was consistent with the result by Wang et al. reported [12].
Energy transfer between TETD and BSA/HSA
Energy transfer between drugs and proteins usually can be di-
vided into two kinds: radioactive energy transfer and non-radioac-
tive energy transfer. The latter can be explained and determined by
Föster’s energy transfer theory. Therefore, Föster’s energy transfer
theory is often used to calculate the distance between amino acid
residues on proteins and drugs in the binding sites, which will hap-
pen under these conditions [49]: (a) the donor can produce ﬂuores-
cence; (b) the absorption spectrum of the receptor overlaps enough
with the donor’s ﬂuorescence emission spectrum and (c) the dis-
tance between donor and acceptor is less than 8 nm. The efﬁciency
of energy transfer, E, is calculated according to Föster’s energy
transfer theory [49].
E ¼ 1 F=F0 ¼ R60=ðR60 þ r6Þ ð8Þ
where r is the distance from the ligand to the tryptophan residue of
protein, and R0 is the Föster critical distance, at which 50% of theexcitation energy is transferred to the acceptor. It can be calculated
from donor emission and acceptor absorption spectra using Eq. (9):
R60 ¼ 8:8 1025 K2N4UJ ð9Þ
J ¼
R1
0 FðkÞeðkÞk4dkR1
0 FðkÞdk
ð10Þ
In Eq. (9), K2 is the orientation factor related to the geometry of the
donor–acceptor dipole and K2 = 2/3 for random orientation as in
ﬂuid solution; N is the average refractive index of medium in the
wavelength range where spectral overlap is signiﬁcant; U is the
ﬂuorescence quantum yield of the donor; and J is the spectral over-
lap integral between the emission spectrum of donor and the
absorption spectrum of acceptor (Fig. 6), which could be calculated
according to Eq. (10), where, F(k) is the ﬂuorescence intensity of the
donor in the wavelength range from k to k + Dk; e(k) is the molar
absorption coefﬁcient of acceptor at wavelength k. The value of J
could be evaluated by integrating the overlap spectra in Fig. 6 at
k = 300–500 nm. According to Eqs. (8)–(10) and using N = 1.36,
Fig. 7. Synchronous ﬂuorescence spectra of (A) BSA and (B) HSA with different concentrations of TETD at Dk = 15 nm (a) and Dk = 60 nm (b), [BSA] = [HSA] = 5.0 lM, CTETD
(lM) 1–4: 0, 4.0, 8.0 and 12.0, respectively. T = 298 K.
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lowing data were obtained: E = 0.578, J = 5.045  1016 cm3 -
L mol1, R0 = 1.533 nm and r = 1.455 nm for the TETD-BSA system,
and E = 0.583, J = 5.059  1016 cm3 L mol1, R0 = 1.534 nm and
r = 1.451 nm for the TETD-HSA system. Obviously, the donor–accep-
tor distances (r) of above two systems were less than 7 nm [51],
suggesting that the energy transfer from BSA/HSA to TETD occurred
with high probability. Moreover, the acquisition of 0.5R0 < r < 1.5R0
indicated that the calculated results were well-predicted by Föster’s
non-radioactive energy transfer theory [17]. In addition, the binding
distance of TETD to BSA/HSA is shorter than that of tetramethylpyr-
azine (TMPZ) to BSA/HSA (2.033/2.045 nm) [45], which suggest that
the binding afﬁnity of TETD with BSA/HSA is stronger than that of
TMPZ to BSA/HSA. The result is consistent with ﬂuorescence spectra
results obtained [45].Study of BSA/HSA conformation
In order to explore the structural changes of BSA and HSA in the
presence of TETD, synchronous ﬂuorescence, three-dimensional
ﬂuorescence and FT-IR spectra of BSA/HSA were analyzed both be-
fore and after the addition of TETD, respectively.Fig. 8. The synchronous ﬂuorescence quenching degree of BSA (A) and HSA (B) by
TETD; [BSA] = [HSA] = 5.0 lM.Synchronous ﬂuorescence spectroscopy studies. Synchronous ﬂuo-
rescence spectra (SFS) can give information about the molecular
environment in the vicinity of a chromophore (such as, tryptophan
(Trp) and tyrosine (Tyr) residues) and it involves simultaneous
scanning of the excitation and emission monochromators while
maintaining a constant wavelength interval (Dk) between them.
SFS is a useful probe to investigate the environment of Tyr and
Trp residues by measuring the possible shift in maximum emission
wavelength. When Dk is stabilized at 15 and 60 nm, the SFS offers
the characteristics of Tyr and Trp residues, respectively [52]. The
effect of TETD on BSA and HSA synchronous ﬂuorescence spectra
Fig. 9. Three-dimensional ﬂuorescence spectra of BSA (A), BSA-TETD system (B), HSA (C) and HSA-TETD system (D); conditions: c(BSA) = c(HSA) = 5.0 lM, c(TETD) = 6.0 lM,
pH = 7.4, T = 298 K.
Table 5
Three-dimensional ﬂuorescence characteristic parameters of SA and TETD-SA
systems.
Peak SA TETD-SA F0/F
Peak position Intensity Peak position Intensity
kex/kem (nm/nm) F0 kex/kem (nm/nm) F0
BSA
A 298/300 57.5 308/310 126.1
B 280/340 780.5 280/340 463.5 1.68
C 236/340 254.1 236/335 173.2 1.47
HSA
A 306/310 67.2 332/335 350.9
B 280/340 774.6 280/335 458.4 1.69
C 236/335 248.4 236/335 184.5 1.35
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length of Tyr and Trp residues showed signiﬁcant red shift, which
indicated that the conformation of BSA/HSA altered such that the
polarity around the Tyr and Trp residues decreased and the hydro-
phobicity was increased [53].
However, it could be seen from Fig. 8 that the ﬂuorescence
intensity quenching of Trp residues was decreased by 54.35%/
57.75% with the addition of TETD, which indicated that TETD
reached subdomain IIA, where only one Trp residues (Trp-212/
Trp-214) on BSA/HSA was located. There was a large hydrophobic
cavity in subdomain IIA where many drugs could be bound. Be-
sides, the ﬂuorescence intensity of Tyr residues on BSA/HSA was
decreased by 46.48%/46.36% in the presence of TETD. Therefore,
the quenching of ﬂuorescence intensity of Trp residues was stron-
ger than that of Tyr residues, suggesting that Trp residues contrib-
uted more to the quenching of the intrinsic ﬂuorescence. These
results implied that TETD was closer to Trp residues compared toTyr residues, or the binding site was mainly focused on tryptophan
moiety. This conclusion agreed well with the results of the dis-
placement experiments.
Three-dimensional ﬂuorescence spectra analysis. Three-dimensional
ﬂuorescence spectrum has become a popular ﬂuorescence analysis
technique in recent years because it can provide more detailed
information about the conformational change of protein. If there
is a shift at the excitation or emission wavelength around the ﬂuo-
rescence peak, or a new peak appears or the existing peak disap-
pears, this can be considered as an important hint to suggest the
conformational change of protein. The conformational and micro-
environmental changes of BSA and HSA were investigated by com-
paring their spectral characteristics in the absence and presence of
TETD, as shown in Fig. 9, and corresponding characteristic param-
eters are listed in Table 5.
Three peaks can be seen in Fig. 9. Peak A is the ﬁrst-ordered Ray-
leigh scattering peak (kex = kem); Peak B (kex = 280 nm, kem = 340 -
nm) relates to the spectral characteristic of Trp and Tyr residues;
Peak C (kex = 236 nm, kem = 335 nm) mainly reveals the spectral
behavior of polypeptide backbone structure, and its ﬂuorescence
intensity is correlated with the secondary structure of protein
[54]. The ﬂuorescence intensity of Peak A increased with the addi-
tion of TETD. It could be attributed to TETD-BSA/HSA complexes that
made thevolumeofBSA/HSA increased,which in turn resulted in the
enhancement of the scattering effect [55]. For the TETD-BSA com-
plex, the ﬂuorescence intensities of Peak B and C decreased with
the addition of TETD.Moreover, themaximumemissionwavelength
of Peak Cwas slightly blue shifted (Table 5). For the TETD-HSA com-
plex, the ﬂuorescence intensities of two strong peaks also decreased
and the maximum emission wavelength of Peak B was slightly
shifted towards shorter wavelength in the presence of TETD
Fig. 10. FT-IR spectra in the region of 1800–1000 cm1 for free BSA (0.10 mM), BSA-TETD complex (the molar ratios of BSA to TETD were maintained at 1:1.4 and 1:4), and
their corresponding difference spectra (indicated in the ﬁgure). The contributions of TETD are subtracted from different spectra in this region, respectively.
Fig. 11. FT-IR spectra in the region of 1800–1000 cm1 for free HSA (0.10 mM), HSA-TETD complex (the molar ratios of HSA to TETD were maintained at 1:1.4 and 1:4), and
their corresponding difference spectra (indicated in the ﬁgure). The contributions of TETD are subtracted from different spectra in this region, respectively.
Table 6
The effects of common ions on the binding constants of TETD-BSA and TETD-HSA systems. c(BSA) = c(HSA) = 5.0 lM, and the concentrations of nine ions are 14.47 lM, T = 298 K.
Ions TETD-BSA TETD-HSA
Ksv(105 L mol1) R SD Ksv (105 L mol1) R SD
– 1.74 0.9921 0.1167 1.75 0.9973 0.0994
Ca2+ 1.89 0.9912 0.1336 1.92 0.9932 0.1193
Zn2+ 1.84 0.9917 0.1262 1.90 0.9938 0.1129
Mg2+ 1.77 0.9926 0.1147 1.81 0.9927 0.1163
Fe3+ 1.52 0.9951 0.0780 1.60 0.9930 0.1005
Cu2+ 1.71 0.9937 0.1017 1.64 0.9928 0.1043
Ni2+ 1.80 0.9941 0.1044 1.68 0.9976 0.0612
Cl 1.83 0.9903 0.1358 1.74 0.9940 0.1012
CH3COO 1.86 0.9905 0.1366 1.80 0.9909 0.1295
C5H7O5COO 1.88 0.9911 0.1332 1.79 0.9935 0.1089
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characteristics of the peaks revealed that the binding site was near
Trp and Tyr residues on BSA/HSA and TETD binding induced the
quenching of intrinsic ﬂuorescence of proteins. The binding of TETD
induced the slight unfolding of the polypeptides of BSA/HSA.
FT-IR spectra analysis. The interactions between TETD and BSA/HSA
were characterized by infrared spectroscopy. Since there were nomajor spectral shifts for BSA and HSA amide I band at 1654 cm1
(mainly C@O stretch) and amide II band at 1548 cm1 (CAN
stretching coupled with NAH bending modes) in the presence of
TETD, the difference spectra [(protein solution + TETD solution) –
(protein solution)] were obtained to monitor the intensity changes
of these vibrations, and their results are shown in Figs. 10 and 11.
At low TETD concentration (0.14 mM), the intensities of amide I
(1654 cm1) and amide II (1548 cm1) of BSA/HSA were increased
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spectra for amide I and II bands at 1653 and 1548 cm1 (BSA),
and 1653 and 1549 cm1 (HSA) in the TETD-BSA and TETD-HSA ad-
ducts (Figs. 10 and 11). These positive features are related to an in-
crease in the intensity of the amide I and II bands upon TETD
complexation. The increase in intensity of the amide I and II bands
is due to TETD binding to C@O, CAN, and NAH groups of proteins
[16,56]. However, when the concentration o TETD increased to
0.40 mM, the intensity changes were observed for BSA/HSA amide
I band at 1640/1648 cm1 and amide II band at 1547/1549 cm1,
and negative features were observed in the difference spectra for
the amide I and II bands at 1653 and 1550 cm1 (BSA), 1653 and
1547 cm1 (HSA) in the BSA-TETD and HSA-TETD systems, respec-
tively (Figs. 10 and 11). For BSA/HSA-TETD complexes, the intensi-
ties of the amide I band of BSA/HSA at 1654 cm1 decreased,
suggesting that the percentage content of a-helical structure of
proteins decreased at high concentration of TETD [16,56].Inﬂuences of common ions on the interactions of TETD with BSA/HSA
Metal ions are vital to human body and play an essentially
structural role in many proteins based coordinate bonds. In plas-
ma, there are some metal ions, which participate in many bio-
chemical processes and affect possibly the interactions of drugs
with serum albumins. Hence, in the paper, the effects of common
ions (such as, Ca2+, Zn2+, Mg2+, Fe3+, Cu2+, Ni2+, Cl, CH3COO and
C5H7O5COO) on the binding of TETD with BSA/HSA were investi-
gated at 298 K. The Stern–Volmer quenching constants (Ksv) of
TETD-BSA and TETD-HSA systems were analyzed by the Stern–
Volmer equation (Eq. (4)) with the addition of above common ions,
and their results were listed in Table 6. As could be seen in Table 6,
the Stern–Volmer quenching constants of TETD-BSA and TETD-HSA
complexes decreased in the presence of Fe3+ or Cu2+ ions, suggest-
ing that the two common ions may compete for the same binding
sites on BSA or HSA. This implied that there was the competition
between the drug and Fe3+ or Cu2+ ions when both of them existed
in the serum albumin solution at the same time. Moreover, the
Stern–Volmer quenching constants of TETD to BSA/HSA increased
with the addition of any one among ﬁve common ions (Ca2+,
Zn2+, Mg2+, CH3COO and C5H7O5COO), which possibly results
from two aspects as follows: the metal ion-TETD complexes are
formed via metal ion bridge, may enhance the binding capability
of the drug to BSA/HSA; Ca2+, Zn2+, Mg2+, CH3COO- or C5H7O5COO
ions can change the conformation of proteins, which is more favor-
able for TETD binding to BSA/HSA. Therefore, in the presence of
common ions, it may be prolonged or shortened to the storage time
of the drug (TETD) in blood plasma. In such an event, it is necessi-
tated to readjust the dose limits of the drug with the addition of
these common ions.Conclusions
In this paper, the interactions of TETD with two SAs were eluci-
dated at the molecular level using spectroscopy with the aid of
MCR-ALS method under physiological conditions. By conventional
method, TETD can quench the ﬂuorescence spectra of BSA/HSA via
a combined quenching (static and dynamic) procedure. The ther-
modynamic parameters indicated that the two binding reactions
were spontaneous process. There is one class of binding sites be-
tween TETD and BSA/HSA most likely binding to Trp-212/Trp-
214 located in subdomain IIA. Synchronous ﬂuorescence, 3D ﬂuo-
rescence and FTIR spectral results revealed that the secondary
structure and the microenvironment of BSA/HSA altered with the
addition of TETD. By MCR-ALS technique, the simultaneous recov-
ery of the concentration proﬁles and pure spectra for the analyseswas possible. So, free TETD, free BSA/HSA and especially TETD-BSA/
HSA complex spectra can been extracted successfully from the
overlapping spectra by MCR-ALS method, which is of particular
signiﬁcance because the extraction of TETD-BSA/HSA complex
can further help to understand the mechanism of the binding. In
addition, the comparisons of binding afﬁnity between TETD deriv-
atives and proteins are worthy to be explored in the future because
they are likely to provide useful information for synthesizing its
analogues with effective pharmacological properties.
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